Marco Investment Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-26,722
Closed -$4.73M 170
2020
Q1
$4.73M Sell
26,722
-375
-1% -$70.6K 1% 33
2019
Q4
$5.18M Sell
27,097
-935
-3% -$169K 0.8% 38
2019
Q3
$4.72M Hold
28,032
0.81% 41
2019
Q2
$4.69M Buy
28,032
+5,950
+27% +$824K 0.84% 39
2019
Q1
$3.23M Buy
22,082
+467
+2% +$67.7K 0.6% 51
2018
Q4
$2.89M Sell
21,615
-101,240
-82% -$16.6M 0.57% 55
2018
Q3
$23.4M Sell
122,855
-19,750
-14% -$3.63M 3.33% 2
2018
Q2
$23.8M Buy
142,605
+555
+0.4% +$89.1K 3.69% 2
2018
Q1
$23.9M Buy
142,050
+106,195
+296% +$17.8M 3.71% 2
2017
Q4
$5.87M Buy
35,855
+18,581
+108% +$3.33M 0.89% 40
2017
Q3
$3.54M Buy
+17,274
New +$4.02M 0.55% 57

Other funds holding AGN

Marco Investment Management's AGN Position: Q2 2020 in Review

Marco Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 26,722 shares — an estimated $4.73M sold.

Marco Investment Management first reported a position in AGN in Q3 2017 and held it in 11 quarters. The position peaked at $23.9M in Q1 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Marco Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Marco Investment Management sold 26,722 Allergan plc shares in Q2 2020, an estimated $4.73M.
  • Marco Investment Management first reported a position in Allergan plc in Q3 2017 and held it in 11 quarters.
  • Marco Investment Management's Allergan plc position peaked at $23.9M in Q1 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Marco Investment Management's 13F filing for Q2 2020, filed 21 Jul 2020.